Share Recommendations

10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19

Abcam still offers abundant growth BUY 30/03/2010

Many people are comparing online antibodies vendor Abcam to Amazon and even Google, such has been its success.

Sector: General Retailers

Companies: Abcam

Profiting from the Personal touch STRONG BUY 30/03/2010

Insurance and employee benefits concern Personal Group Holdings has performed strongly throughout the recession, so much so that it enjoyed a second consecutive record year for new business in 2009.

Sector: General Financial

Companies: Personal

TEG picks up sweet smell of success BUY 30/03/2010

Where there’s muck, there’s brass, runs the old adage. One entrepreneur out to prove it is as true today as ever is Michael Fishwick, chief executive of organic composting specialist TEG Group.

Sector: Industrial Engineering

Companies: TEG (formerly TEG Environmental)

Altona Energy HOLD 30/03/2010

Altona Energy has upset investors by raising £3m at a deeply discounted 9p for its Arckaringa coal-to-liquids project Down Under.

Tags: AIM , Commodities , Fundraisings , Turnaround

Sector: Mining

Companies: Altona Energy

Northbridge Industrial Services BUY/HOLD 29/03/2010

Despite recessionary pressure, international industrial services and rental play Northbridge has remained profitable while investing in its fleet ahead of upturn.

Tags: AIM , Cash , Dividends , Mergers & acquisitions

Sector: Industrial Engineering

Companies: Northbridge Industrial Services

Southern Cross Healthcare Group SELL 29/03/2010

Occupancy rates and local authority fee settlements have both fallen below management expectations, warns Southern Cross Healthcare.

Tags: Deals & contracts , Full list , Profit warnings , Restructuring

Sector: Health Care Equipment & Services

Companies: Southern Cross Healthcare Group

GW Pharmaceuticals REDUCE 25/03/2010

GW Pharmaceuticals says Phase IIb preliminary results for its Sativex cancer pain treatment support moving to the next US trial phase.

Tags: AIM , Deals & contracts

Sector: Pharmaceuticals & Biotechnology

Companies: GW Pharmaceuticals

Alliance Pharma HOLD 24/03/2010

Speciality drug company Alliance Pharma has lifted annual pre-tax profits by 134% to £5.7m and is looking for further acquisitions.

Tags: AIM , Fundraisings , Growth Stocks , Mergers & acquisitions

Sector: Pharmaceuticals & Biotechnology

Companies: Alliance Pharma

Straight BUY 23/03/2010

Recycling products group Straight has delighted followers with some significantly improved financials for a transformational 2009.

Tags: AIM , Dividends , Mergers & acquisitions , Turnaround

Sector: Chemicals

Companies: Straight

Netcall SPECULATIVE BUY 23/03/2010

Following a first half dimmed by some product sales 'slippage', call-back, auto-messaging and workforce management solutions specialist Netcall has dialled in news of a better start to the second half-year.

Tags: AIM , Mergers & acquisitions , Speculative punts , Technology , Undervalued

Sector: Software & Computer Services

Companies: Netcall

Tarsus Group STRONG BUY 23/03/2010

An increasing emerging markets emphasis helped resilient exhibitions business Tarsus to a record 2009.

Tags: Dividends , Emerging markets , Full list , Growth Stocks

Sector: Media

Companies: Tarsus Group

Asterand HOLD 23/03/2010

Asterand, a leading supplier of human-based tissue samples and bio-fluids and a pioneer in applying 'predictive human biology' to drug discovery, has signed a collaboration agreement with Japan's Ono Pharmaceutials.

Tags: Deals & contracts , Full list , Turnaround

Sector: Pharmaceuticals & Biotechnology

Companies: Asterand

10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
18 |
19

VCT Report 2010

VCT Report 2010 uncovers the money available

for investment in every single VCT, helping you get one step ahead in the race to attract funding for your unquoted, AIM-listed or PLUS-quoted

company.

Order VCT Report 2010 today using this online form

Cash Shells Directory 2010

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape. For more information and to order, click here or contact our marketing team on 020 7250 7056.

Coverage of AIM, techMARK and PLUS Markets

Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.

Take control of your investments

A full year's subscription to What Investment magazine for £19.95, a whopping 58% off. Get the latest news, features and expert advice on ISAs, Investment Trusts and Funds, SIPPS, Investing for Children and much much
more. Find out more here.

The Financial Times Guide to Personal Tax

is the definitive and most up-to-date guide to completing your self-assessment tax return, making sure that you get it right and on time, and showing how you can save tax. For more information and to order, click here or contact our marketing team on 020 7250 7056.

The AIM Guide Spring 2010

The new, fully updated AIM Guide is now available to buy for only £49.95 (saving you £30).

A 'must-have' for any serious investor or professional interested in the market for young, fast-growing companies. Order your copy today Hurry, as offer ends soon!